Gene-Edited Dogs Coming For Military

The intersection of biotechnology and military procurement has produced a significant new entrant focused on enhancing the biological assets of the armed forces. On October 23, 2026, Warhound announced it has secured two hundred million dollars in funding to develop gene-edited dogs for the United States military.

The startup operates as a joint venture involving Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril. According to statements made to Wired, the company has already begun modifying the genetic material of cell samples taken from its initial group of donor animals. These samples were sourced from high-performing military, police, and first responder dogs across the nation. The primary breeds involved are Belgian Malinois, with a smaller number of Labrador Retrievers and German Shepherds included in the pool.

Scientists at Colossal Biosciences will handle the genetic modifications and subsequent cloning process. The initial phase of research targets the reduction of hereditary health issues common to these breeds, specifically hip dysplasia and certain forms of cancer. Lamm indicated to TechCrunch that future iterations of the program may focus on performance traits. Potential enhancements include increased speed, greater agility, and a sharper olfactory capacity.

The leadership team brings considerable experience from the technology and defense sectors. Luckey, known for founding Oculus VR and creating the Oculus Rift, leads Anduril. That company recently won a contract with the US Army to build a next-generation battlefield intelligence system in partnership with Palantir. It also collaborated with OpenAI in 2024 to develop artificial intelligence tools for the Pentagon. Lamm’s firm, Colossal Biosciences, is currently pursuing several de-extinction projects, including efforts to revive the dire wolf and the woolly mammoth.

While the biological engineering is handled by Colossal, Anduril’s contribution is strictly equipment-based. The company will design the hardware and software intended to protect the animals during operations. This includes items such as goggles, vests, and body armor. There are no immediate plans to create cyborg canines, suggesting a focus on enhancing existing biological capabilities with advanced gear rather than mechanical integration.

The corporate structure places David Spirk, a former executive at Palantir, in the role of chief executive officer. Although Luckey is a partner in the business, neither he nor Anduril holds an equity stake in the startup. Colossal Biosciences retains ownership shares, and Lamm serves on the board of directors. The company anticipates that the first batch of genetically engineered dogs will be born in early 2027. These animals will undergo training for standard working dog duties, including bomb detection and search and rescue operations.

The project represents a notable shift in how defense agencies approach canine units, moving beyond traditional breeding to precise genetic editing. By combining the biological expertise of Colossal with the hardware capabilities of Anduril, Warhound aims to produce dogs that are both healthier and better equipped for the demands of modern military service.